Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Mol Biol (Mosk) ; 57(4): 692-705, 2023.
Article de Russe | MEDLINE | ID: mdl-37528790

RÉSUMÉ

Developing physiologically meaningful mathematical models that describe multilevel regulation in a complex network of immune processes, in particular, of the system of interferon-regulated virus production processes, is a fundamental scientific problem, within the framework of an interdisciplinary systems approach to research in immunology. Here, we have presented a detailed high-dimensional model describing HIV (human immunodeficiency virus) replication, the response of type I interferon (IFN) to the virus infection of the cell, and suppression of the action of IFN-induced proteins by HIV accessory proteins. As a result, this model includes interactions of all three processes for the first time. The mathematical model is a system of 37 nonlinear ordinary differential equations including 78 parameters. Importantly, the model describes not only the processes of the IFN response of the cell to virus infection, but also the mechanisms used by the virus to prevent effects of the IFN system.


Sujet(s)
Infections à VIH , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Maladies virales , Humains , Interférons/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Infections à VIH/métabolisme , Réplication virale
2.
Int Rev Immunol ; 32(3): 282-306, 2013 Jun.
Article de Anglais | MEDLINE | ID: mdl-23617796

RÉSUMÉ

Infections with HIV represent a great challenge for the development of strategies for an effective cure. The spectrum of diseases associated with HIV ranges from opportunistic infections and cancers to systemic physiological disorders like encephalopathy and neurocognitive impairment. A major progress in controlling HIV infection has been achieved by highly active antiretroviral therapy (HAART). However, HAART does neither eliminate the virus reservoirs in form of latently infected cells nor does it completely reconstitute immune reactivity and physiological status. Furthermore, the failure of the STEP vaccine trial and the only marginal efficacies of the RV144 trial together suggest that the causal relationships between the complex sets of viral and immunological processes that contribute to protection or disease pathogenesis are still poorly understood. Here, we provide an up-to-date overview of HIV-host interactions at the cellular, the immune system and the neuroendocrine systems level. Only by integrating this multi-level knowledge one will be able to handle the systems complexity and develop new methodologies of analysis and prediction for a functional restoration of the immune system and the health of the infected host.


Sujet(s)
Vaccins contre le SIDA/usage thérapeutique , Infections à VIH/immunologie , Infections à VIH/thérapie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Système immunitaire/immunologie , Système neuroendocrinien/immunologie , Animaux , Thérapie antirétrovirale hautement active , Communication cellulaire , Essais cliniques comme sujet , Infections à VIH/traitement médicamenteux , Humains , Système immunitaire/virologie , Immunité cellulaire , Système neuroendocrinien/virologie , Échec thérapeutique , Réplication virale
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE